Pulmonary hypertension (PH) is common in severe symptomatic aortic stenosis (AS) with some studies reporting the incidence to be as high as 50% [ 1 ]. Studies of surgical aortic valve replacement in patients with concomitant PH point towards it being a negative prognostic indicator [ 2 ]. Previous small-scale studies suggested a similar association in patients undergoing transcatheter aortic valve implantation (TAVI) [ 3 , 4 ]. We sought to assess the impact of PH on morbidity, mortality, and resource utilization among patients undergoing TAVI using contemporary nationwide database.